Fortnightly Review: Diagnosis and management of migraine

BMJ 1996;312:1279-1283 (18 May)

Education and debate

Fortnightly Review: Diagnosis and management of migraine

Peter J Goadsby, reader in clinical neurology,^a Jes Olesen, professor of neurology ^b

^a Institute of Neurology, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, ^b Department of Neurology, Glostrup Hospital, Glostrup, Denmark

Correspondence to: Dr Goadsby.

Summary points

Before a primary headache such as migraine is diagnosed, secondary headaches should be considered and eliminated on clinical grounds or by appropriate investigations
Migraine is primarily diagnosed by eliciting a history of episodic headache with characteristic associated features. The use of diagnostic headache diaries and simple calendars is strongly encouraged
Optimum treatment of migraine requires explaining the problem to the patient and identifying and avoiding precipitating factors
Treatment may be non-pharmacological or pharmacological. Drugs may be for treating acute attacks, which is required by nearly all patients, or prophylaxis, which is used by patients with frequent severe attacks
Treatment for an acute attack should result in mild or no headache by two hours after drug ingestion, while prophylactic treatment should result in a 50% reduction in the frequency of attacks
Characterisation of the 5-hydroxytryptamine receptor of the 5-HT1 class has provided better treatments for acute attack and impetus for studying mechanism of migraine

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to StumbleUpon StumbleUpon Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Mortelmans, K., Post, M., Thijs, V., Herroelen, L., Budts, W. (2005). The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 26: 1533-1537 [Abstract] [Full text]
Zlotnik, G., Heckmann, J.G., Lang, C.J. G., Neundorfer, B., Milhaud, D., Bogousslavsky, J. (2002). Ischemic stroke and active migraine. Neurology 59: 149-150 [Full text]
Heckmann, J., Lang, C., Dietrich, W, Neidhardt, B, Neundorfer, B (2002). Symptomatic Migraine Linked To Stroke Due To Paradoxical Embolism and Elevated Thrombosis Risk. Cephalalgia 22: 154-156 [Full text]
Goadsby, P. J., Lipton, R. B., Ferrari, M. D. (2002). Migraine -- Current Understanding and Treatment. NEJM 346: 257-270 [Full text]
Rahimtoola, H, Egberts, A., Buurma, H, Tijssen, C., Leufkens, H. (2001). Patterns of Ergotamine and Sumatriptan Use in the Netherlands from 1991 to 1997. Cephalalgia 21: 596-603 [Abstract] [Full text]
The Diclofenac-K/Sumatriptan Migraine Study Group, (1999). Acute Treatment of Migraine Attacks: Efficacy and Safety of A Nonsteroidal Anti-Inflammatory Drug, Diclofenac-Potassium, in Comparison To Oral Sumatriptan and Placebo. Cephalalgia 19: 232-240 [Abstract]
Brown, A. D, Dodson, P. M, Ainsworth, J. R (1996). Diagnosis and management of migraine. BMJ 313: 691-691 [Full text]
Lock, J., Gallagher, D. (1996). Care needs to be taken with treatment. BMJ 313: 691a-691 [Full text]
Nelson-Piercy, C., De Swiet, M. (1996). Low dose aspirin may be used for prophylaxis. BMJ 313: 691b-691 [Full text]